Asianet Newsable on MSN
Fitch sees stable 2026 outlook for global pharma — but warns Trump drug pricing push poses profit risk
Fitch believes companies with portfolios focused on oncology, immunology, rare diseases, vaccines and metabolic or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback